TRAIL: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
'''TRAIL (TNF-related apoptosis-inducing ligand)''' or '''TNF ligand superfamily 10''' functions as a ligand in the process of apoptosis<ref>PMID:15987601</ref>. TRAIL binds to death receptors DR4, DR5, DcR1 and DcR2. For details see [[Molecular Playground/TRAIL]]. '''TRAIL-R2''' is called '''DR5'''. <scene name='48/480878/Cv/3'>TRAIL trimer residues complex with death receptor-5 extracellular domain</scene> ([[1d0g]]). <scene name='48/480878/Cv/4'>Zn+2 and Cl-1 bind to 3 same Cys residues from different subunits of TRAIL trimer</scene>. | '''TRAIL (TNF-related apoptosis-inducing ligand)''' or '''TNF ligand superfamily 10''' functions as a ligand in the process of apoptosis<ref>PMID:15987601</ref>. TRAIL binds to death receptors DR4, DR5, DcR1 and DcR2. For details see [[Molecular Playground/TRAIL]]. '''TRAIL-R2''' is called '''DR5'''. <scene name='48/480878/Cv/3'>TRAIL trimer residues complex with death receptor-5 extracellular domain</scene> ([[1d0g]]). <scene name='48/480878/Cv/4'>Zn+2 and Cl-1 bind to 3 same Cys residues from different subunits of TRAIL trimer</scene>. | ||
See also: [[Cytokine receptors]] | See also: | ||
*[[Cytokine receptors]] | |||
*[[Immune receptors]] | |||
== Disease == | == Disease == | ||
Latest revision as of 07:51, 12 January 2023
| ||||||||||||
3D Structures of TRAIL
Updated on 12-January-2023
TRAIL-R2 domains – extracellular 54-184; transmembrane 208-242
Molecular Playground/TRAIL, 1d0g, Cytokine receptors, Immune receptors - hTRAIL 114-281 + TRAIL-R2 extracellular domain - human
4n90 - hTRAIL 114-281 + hTRAIL-R2 extracellular domain + antibody
1dg6 – hTRAIL jelly-roll domain 91-281
1d2q - hTRAIL 114-281
4i9x – hTRAIL-R2 extracellular domain + UL141
3x3f, 1za3, 4od2, 2h9g, 6t3j – hTRAIL-R2 extracellular domain + antibody
6nhw – hTRAIL-R2 transmembrane domain - NMR
6nhy – hTRAIL-R2 transmembrane domain (mutant) - NMR